NO20071343L - Substituerte fenylaminotiazoler og anvendelse derav - Google Patents
Substituerte fenylaminotiazoler og anvendelse deravInfo
- Publication number
- NO20071343L NO20071343L NO20071343A NO20071343A NO20071343L NO 20071343 L NO20071343 L NO 20071343L NO 20071343 A NO20071343 A NO 20071343A NO 20071343 A NO20071343 A NO 20071343A NO 20071343 L NO20071343 L NO 20071343L
- Authority
- NO
- Norway
- Prior art keywords
- phenylaminothiazoles
- substituted
- diseases
- prevention
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Foreliggende oppfinnelse angår nye fenylaminotiazol derivater, fremgangsmåter for fremstilling derav, anvendelse derav for behandling og/eller hindring av sykdommer og anvendelse derav for fremstilling av medikamenter anvendt for behandling og/eller hindring av sykdommer, foretrukket hypertensjon og andre kardiovaskulære sykdommer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004042607A DE102004042607A1 (de) | 2004-09-03 | 2004-09-03 | Substituierte Phenylaminothiazole und ihre Verwendung |
PCT/EP2005/009316 WO2006027142A1 (de) | 2004-09-03 | 2005-08-30 | Substituierte phenylaminothiazole und ihre verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20071343L true NO20071343L (no) | 2007-05-30 |
Family
ID=35852458
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20071343A NO20071343L (no) | 2004-09-03 | 2007-03-13 | Substituerte fenylaminotiazoler og anvendelse derav |
Country Status (24)
Country | Link |
---|---|
US (1) | US8691850B2 (no) |
EP (1) | EP1812430B1 (no) |
JP (1) | JP4999691B2 (no) |
KR (1) | KR20070057235A (no) |
CN (1) | CN101056875A (no) |
AR (1) | AR050551A1 (no) |
AT (1) | ATE428710T1 (no) |
AU (1) | AU2005281941A1 (no) |
BR (1) | BRPI0514833A (no) |
CA (1) | CA2578596C (no) |
DE (2) | DE102004042607A1 (no) |
EC (1) | ECSP077296A (no) |
ES (1) | ES2324049T3 (no) |
GT (1) | GT200500238A (no) |
IL (1) | IL181670A0 (no) |
MA (1) | MA28869B1 (no) |
MX (1) | MX2007002470A (no) |
NO (1) | NO20071343L (no) |
PE (1) | PE20060589A1 (no) |
SV (1) | SV2006002218A (no) |
TW (1) | TW200621765A (no) |
UY (1) | UY29099A1 (no) |
WO (1) | WO2006027142A1 (no) |
ZA (1) | ZA200701820B (no) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102006009813A1 (de) * | 2006-03-01 | 2007-09-06 | Bayer Healthcare Ag | Verwendung von A2b/A1 Rezeptor Agonisten zur Modulation der Lipidspiegel |
DE102006042143A1 (de) * | 2006-09-08 | 2008-03-27 | Bayer Healthcare Aktiengesellschaft | Neue substituierte Bipyridin-Derivate und ihre Verwendung |
DE102006044696A1 (de) | 2006-09-22 | 2008-03-27 | Bayer Healthcare Ag | 3-Cyano-5-thiazaheteroaryl-dihydropyridine und ihre Verwendung |
DE102006056740A1 (de) | 2006-12-01 | 2008-06-05 | Bayer Healthcare Ag | Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung |
DE102006056739A1 (de) * | 2006-12-01 | 2008-06-05 | Bayer Healthcare Ag | Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung |
DE102007035367A1 (de) * | 2007-07-27 | 2009-01-29 | Bayer Healthcare Ag | Substituierte Aryloxazole und ihre Verwendung |
DE102007036076A1 (de) | 2007-08-01 | 2009-02-05 | Bayer Healthcare Aktiengesellschaft | Dipeptoid-Produgs und ihre Verwendung |
DE102007061763A1 (de) * | 2007-12-20 | 2009-06-25 | Bayer Healthcare Ag | Substituierte azabicyclische Verbindungen und ihre Verwendung |
DE102007061764A1 (de) | 2007-12-20 | 2009-06-25 | Bayer Healthcare Ag | Anellierte Cyanopyridine und ihre Verwendung |
DE102008008838A1 (de) | 2008-02-13 | 2009-08-20 | Bayer Healthcare Ag | Cycloalkoxy-substituierte 4-Phenyl-3,5-dicyanopyridine und ihre Verwendung |
DE102008013587A1 (de) * | 2008-03-11 | 2009-09-17 | Bayer Schering Pharma Aktiengesellschaft | Heteroaryl-substituierte Dicyanopyridine und ihre Verwendung |
JP2011520997A (ja) * | 2008-05-29 | 2011-07-21 | バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト | 2−アルコキシ置換ジシアノピリジン類およびそれらの使用 |
DE102008062567A1 (de) | 2008-12-16 | 2010-06-17 | Bayer Schering Pharma Aktiengesellschaft | Dipeptoid-Prodrugs und ihre Verwendung |
DE102009006602A1 (de) * | 2009-01-29 | 2010-08-05 | Bayer Schering Pharma Aktiengesellschaft | Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs |
DE102009022894A1 (de) * | 2009-05-27 | 2010-12-02 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
DE102010030688A1 (de) | 2010-06-30 | 2012-01-05 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Dicyanopyridine und ihre Verwendung |
KR20220147691A (ko) | 2013-08-09 | 2022-11-03 | 알데릭스, 인코포레이티드 | 인산염 수송을 억제하기 위한 화합물 및 방법 |
WO2018153895A1 (de) | 2017-02-22 | 2018-08-30 | Bayer Pharma Aktiengesellschaft | Selektive partielle adenosin a1 rezeptor-agonisten in kombination mit einem inhibitor der neutralen endopeptidase und/oder einem angiotensin ii rezeptor-antagonisten |
WO2018153898A1 (de) | 2017-02-22 | 2018-08-30 | Bayer Pharma Aktiengesellschaft | Selektive partielle adenosin a1 rezeptor-agonisten in kombination mit mineralocorticoid-rezeptor-antagonisten |
WO2018153900A1 (de) | 2017-02-22 | 2018-08-30 | Bayer Aktiengesellschaft | Selektive partielle adenosin a1 rezeptor-agonisten in kombination mit sglt-2-hemmern |
WO2018153899A1 (de) | 2017-02-22 | 2018-08-30 | Bayer Pharma Aktiengesellschaft | Selektive partielle adenosin a1 rezeptor-agonisten in kombination mit stimulatoren und/oder aktivatoren der löslichen guanylatcyclase (sgc) |
WO2018153897A1 (de) | 2017-02-22 | 2018-08-30 | Bayer Pharma Aktiengesellschaft | Selektive partielle adenosin a1 rezeptor-agonisten in kombination mit hcn-kanal-hemmern |
JP7323913B2 (ja) * | 2019-04-12 | 2023-08-09 | 国立大学法人 筑波大学 | 睡眠誘導剤である複素環化合物 |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW299333B (no) | 1992-12-29 | 1997-03-01 | Takeda Pharm Industry Co Ltd | |
CN1056611C (zh) | 1994-06-16 | 2000-09-20 | 美国辉瑞有限公司 | 吡唑并吡啶和吡咯并吡啶,其用途和用于制备它们的中间体 |
JPH09132529A (ja) | 1995-11-09 | 1997-05-20 | Ono Pharmaceut Co Ltd | 一酸化窒素合成酵素阻害剤 |
CN1158290C (zh) | 1996-01-17 | 2004-07-21 | 诺沃挪第克公司 | 稠合1,2,4-噻二嗪与稠合1,4-噻嗪衍生物、其制备方法及用途 |
JPH10324687A (ja) | 1997-02-19 | 1998-12-08 | Nippon Soda Co Ltd | ピロール化合物、製法および農園芸用殺菌剤 |
WO1998054139A1 (de) | 1997-05-30 | 1998-12-03 | Basf Aktiengesellschaft | Verfahren zur herstellung substituierter thiopyridine |
PL338013A1 (en) | 1997-07-16 | 2000-09-25 | Novo Nordisk As | Derivatives of condensed 1,2,4-thiadiazine, their production and application |
US6632823B1 (en) | 1997-12-22 | 2003-10-14 | Merck & Co., Inc. | Substituted pyridine compounds useful as modulators of acetylcholine receptors |
DE19834047A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Substituierte Pyrazolderivate |
DE19834044A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Neue substituierte Pyrazolderivate |
DE19943636A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE19943635A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE19943634A1 (de) | 1999-09-13 | 2001-04-12 | Bayer Ag | Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE19947154A1 (de) | 1999-10-01 | 2001-10-04 | Bayer Ag | Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
ATE293962T1 (de) | 2000-02-25 | 2005-05-15 | Hoffmann La Roche | Adenosin-rezeptor modulatoren |
AU2001269529A1 (en) | 2000-07-18 | 2002-01-30 | Yamanouchi Pharmaceutical Co., Ltd. | Medicine comprising dicyanopyridine derivative |
AR031176A1 (es) | 2000-11-22 | 2003-09-10 | Bayer Ag | Nuevos derivados de pirazolpiridina sustituidos con piridina |
JP2004515543A (ja) | 2000-12-11 | 2004-05-27 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | 有害無脊椎動物を防除するためのキナゾリノン類およびピリジニルピリミジノン類 |
JP4405726B2 (ja) | 2000-12-21 | 2010-01-27 | ブリストル−マイヤーズ スクイブ カンパニー | Tecファミリーチロシンキナーゼのチアゾリルインヒビター |
DE10110438A1 (de) | 2001-03-05 | 2002-09-19 | Bayer Ag | Substituierte 2-Oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
DE10110754A1 (de) | 2001-03-07 | 2002-09-19 | Bayer Ag | Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
DE10110747A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Substituierte 2,6-Diamino-3,5-dicyano-4-aryl-pyridine und ihre Verwendung |
DE10110750A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE10110749A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Substituierte Aminodicarbonsäurederivate |
DE10115945A1 (de) | 2001-03-30 | 2002-10-02 | Bayer Ag | Substituierte 2-Carba-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
DE10115922A1 (de) | 2001-03-30 | 2002-10-10 | Bayer Ag | Cyclisch substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
DE10134481A1 (de) * | 2001-07-16 | 2003-01-30 | Bayer Ag | Substituierte 2-Thio-3,5-dicyano-4-phenyl-6-aminopyridine und ihre Verwendung |
DE10238113A1 (de) | 2001-12-11 | 2003-06-18 | Bayer Ag | Substituierte 2-Thio-3,5-dicyano-4-phenyl-6-aminopyridine und ihre Verwendung |
JP2003183254A (ja) | 2001-12-20 | 2003-07-03 | Yamanouchi Pharmaceut Co Ltd | 2−アシルアミノ−3,5−ジシアノピリジン誘導体又はその塩 |
AU2003237121A1 (en) | 2002-04-26 | 2003-11-10 | Vertex Pharmaceuticals Incorporated | Pyrrole derivatives as inhibitors of erk2 and uses thereof |
DE10220570A1 (de) | 2002-05-08 | 2003-11-20 | Bayer Ag | Carbamat-substituierte Pyrazolopyridine |
EP1388342A1 (en) | 2002-08-07 | 2004-02-11 | Aventis Pharma Deutschland GmbH | Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
EP1545515A1 (en) | 2002-08-12 | 2005-06-29 | Sugen, Inc. | 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors |
AU2003296414A1 (en) | 2002-12-12 | 2004-07-09 | Pharmacia Corporation | Method of using aminocyanopyridine compounds as mitogen activated protein kinase-activated protein kinase-2 inhibitors |
AR042667A1 (es) | 2002-12-26 | 2005-06-29 | Taisho Pharmaceutical Co Ltd | Derivados de pirrolopirimidina y pirrolopiridina sustituidos con un grupo amino ciclico |
TW200418829A (en) | 2003-02-14 | 2004-10-01 | Avanir Pharmaceutics | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
AR045047A1 (es) | 2003-07-11 | 2005-10-12 | Arena Pharm Inc | Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos |
JP4722851B2 (ja) | 2003-09-23 | 2011-07-13 | メルク・シャープ・エンド・ドーム・コーポレイション | キノリンカリウムチャネル阻害剤 |
US7338951B2 (en) | 2003-11-10 | 2008-03-04 | Synta Pharmaceuticals Corp. | Pyridine compounds |
US20050182105A1 (en) | 2004-02-04 | 2005-08-18 | Nirschl Alexandra A. | Method of using 3-cyano-4-arylpyridine derivatives as modulators of androgen receptor function |
JP2007161585A (ja) | 2004-06-25 | 2007-06-28 | Taisho Pharmaceut Co Ltd | 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体 |
DE102004032651A1 (de) | 2004-07-06 | 2006-02-16 | Bayer Healthcare Ag | Verwendung von substituierten 2-Thio-3,5-dicyano-4-phenyl-6-aminopyriden bei der Behandlung von Übelkeit und Erbrechen |
DE102006042143A1 (de) | 2006-09-08 | 2008-03-27 | Bayer Healthcare Aktiengesellschaft | Neue substituierte Bipyridin-Derivate und ihre Verwendung |
DE102006056739A1 (de) | 2006-12-01 | 2008-06-05 | Bayer Healthcare Ag | Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung |
DE102006056740A1 (de) | 2006-12-01 | 2008-06-05 | Bayer Healthcare Ag | Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung |
DE102007035367A1 (de) | 2007-07-27 | 2009-01-29 | Bayer Healthcare Ag | Substituierte Aryloxazole und ihre Verwendung |
DE102007036076A1 (de) | 2007-08-01 | 2009-02-05 | Bayer Healthcare Aktiengesellschaft | Dipeptoid-Produgs und ihre Verwendung |
DE102008013587A1 (de) | 2008-03-11 | 2009-09-17 | Bayer Schering Pharma Aktiengesellschaft | Heteroaryl-substituierte Dicyanopyridine und ihre Verwendung |
DE102008062567A1 (de) | 2008-12-16 | 2010-06-17 | Bayer Schering Pharma Aktiengesellschaft | Dipeptoid-Prodrugs und ihre Verwendung |
DE102009006602A1 (de) | 2009-01-29 | 2010-08-05 | Bayer Schering Pharma Aktiengesellschaft | Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs |
-
2004
- 2004-09-03 DE DE102004042607A patent/DE102004042607A1/de not_active Withdrawn
-
2005
- 2005-08-30 WO PCT/EP2005/009316 patent/WO2006027142A1/de active Application Filing
- 2005-08-30 US US11/661,820 patent/US8691850B2/en not_active Expired - Fee Related
- 2005-08-30 EP EP05776232A patent/EP1812430B1/de active Active
- 2005-08-30 CN CNA2005800381572A patent/CN101056875A/zh active Pending
- 2005-08-30 KR KR1020077007526A patent/KR20070057235A/ko not_active Application Discontinuation
- 2005-08-30 BR BRPI0514833-2A patent/BRPI0514833A/pt not_active IP Right Cessation
- 2005-08-30 MX MX2007002470A patent/MX2007002470A/es not_active Application Discontinuation
- 2005-08-30 AT AT05776232T patent/ATE428710T1/de not_active IP Right Cessation
- 2005-08-30 CA CA2578596A patent/CA2578596C/en not_active Expired - Fee Related
- 2005-08-30 JP JP2007529331A patent/JP4999691B2/ja not_active Expired - Fee Related
- 2005-08-30 ES ES05776232T patent/ES2324049T3/es active Active
- 2005-08-30 AU AU2005281941A patent/AU2005281941A1/en not_active Abandoned
- 2005-08-30 DE DE502005007106T patent/DE502005007106D1/de active Active
- 2005-09-01 GT GT200500238A patent/GT200500238A/es unknown
- 2005-09-01 AR ARP050103664A patent/AR050551A1/es not_active Application Discontinuation
- 2005-09-02 SV SV2005002218A patent/SV2006002218A/es not_active Application Discontinuation
- 2005-09-02 TW TW094130123A patent/TW200621765A/zh unknown
- 2005-09-02 PE PE2005001012A patent/PE20060589A1/es not_active Application Discontinuation
- 2005-09-05 UY UY29099A patent/UY29099A1/es not_active Application Discontinuation
-
2007
- 2007-03-01 ZA ZA200701820A patent/ZA200701820B/xx unknown
- 2007-03-01 IL IL181670A patent/IL181670A0/en unknown
- 2007-03-02 EC EC2007007296A patent/ECSP077296A/es unknown
- 2007-03-13 NO NO20071343A patent/NO20071343L/no not_active Application Discontinuation
- 2007-03-23 MA MA29769A patent/MA28869B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
UY29099A1 (es) | 2006-04-28 |
PE20060589A1 (es) | 2006-08-12 |
ECSP077296A (es) | 2007-04-26 |
ZA200701820B (en) | 2008-08-27 |
JP4999691B2 (ja) | 2012-08-15 |
SV2006002218A (es) | 2006-10-04 |
CN101056875A (zh) | 2007-10-17 |
EP1812430B1 (de) | 2009-04-15 |
US8691850B2 (en) | 2014-04-08 |
IL181670A0 (en) | 2007-07-04 |
JP2008511614A (ja) | 2008-04-17 |
MA28869B1 (fr) | 2007-09-03 |
US20080269300A1 (en) | 2008-10-30 |
GT200500238A (es) | 2006-04-10 |
BRPI0514833A (pt) | 2008-06-24 |
DE502005007106D1 (de) | 2009-05-28 |
EP1812430A1 (de) | 2007-08-01 |
MX2007002470A (es) | 2009-02-12 |
ES2324049T3 (es) | 2009-07-29 |
AR050551A1 (es) | 2006-11-01 |
DE102004042607A1 (de) | 2006-03-09 |
CA2578596A1 (en) | 2006-03-16 |
CA2578596C (en) | 2012-10-23 |
AU2005281941A1 (en) | 2006-03-16 |
ATE428710T1 (de) | 2009-05-15 |
WO2006027142A1 (de) | 2006-03-16 |
KR20070057235A (ko) | 2007-06-04 |
TW200621765A (en) | 2006-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20071343L (no) | Substituerte fenylaminotiazoler og anvendelse derav | |
NL300933I2 (nl) | Letermovir | |
NO20072461L (no) | Fremstilling og anvendelse av bifenyl-4-yl-karbonylaminosyre derivater for behandling av fedme | |
NO20070081L (no) | Sulfamat og sulfamidderivater for behandling av epilepsi og relaterte sykdommer | |
NO20091655L (no) | Substituerte dihydropyrazoloner for behandling av kardiovaskulaere og hematologiske sykdommer | |
NO20033181L (no) | Substituerte alkylaminderivater og fremgangsmåter for anvendelse | |
NO20084328L (no) | Nye forbindelser | |
NO20084912L (no) | Bisykliske derivater som CETP-inhibitorer | |
MY142589A (en) | Benzimidazole derivatives : preparation and pharmaceutical applications | |
CY1110965T1 (el) | Επιπροσθετες ετεροπολυκυκλικες ενωσεις και η χρηση τους ως ανταγωνιστες μεταβολοτροπικου υποδοχεα γλουταμικου | |
NO20060230L (no) | Nye aminobenzofenonforbindelser | |
CY1112813T1 (el) | 4-(4-κυανο-2-θειοαρυλ)διϋδροπυριμιδινονες και η χρηση αυτων | |
NO20083427L (no) | Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse | |
NO20073574L (no) | Triazolsubstituerte aminobenzofenonforbindelser | |
NO20054083L (no) | Nye sammenkoblede triazoloner og deres anvendelse | |
TW200510325A (en) | 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
NO20085100L (no) | Nye forbindelser | |
NO20055741D0 (no) | Nye kjemiske forbindelser | |
DK2105164T3 (da) | Nye P2X7R-antagonister og deres anvendelse | |
NO20082986L (no) | Nye, acylisk substituerte furopyrimidinderivater og anvendelse derav for behandling av kardiovaskulaere lidelser | |
CY1109569T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης | |
ATE380188T1 (de) | Substituierte chinolone | |
NO20074780L (no) | Heterocyklylamidsubstituerte imidazoler | |
GEP20135733B (en) | Novel diazeniumdiolate derivatives, their preparation method and pharmaceutical compositions containing them | |
NO20076405L (no) | Anvendelse av 24-nor-UDCA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |